Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
Background In ROCKET AF, rivaroxaban was non-inferior to adjusted-dose warfarin in preventing stroke or systemic embolism among patients with atrial fibrillation (AF). We aimed to investigate whether the efficacy and safety of rivaroxaban compared with warfarin is consistent among the subgroups of pati...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
March 7, 2012
|
| In: |
The lancet
Year: 2012, Jahrgang: 11, Heft: 4, Pages: 315-322 |
| ISSN: | 1474-4465 |
| DOI: | 10.1016/S1474-4422(12)70042-X |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/S1474-4422(12)70042-X Verlag, Volltext: http://linkinghub.elsevier.com/retrieve/pii/S147444221270042X 
|
| Verfasserangaben: | Graeme J Hankey, Manesh R Patel, Susanna R Stevens, Richard C Becker, Günter Breithardt, Antonio Carolei, Hans-Christoph Diener, Geoffrey A Donnan, Jonathan L Halperin, Kenneth W Mahaffey, Jean-Louis Mas, Ayrton Massaro, Bo Norrving, Christopher C Nessel, John F Paolini, Risto O Roine, Daniel E Singer, Lawrence Wong, Robert M Califf, Keith AA Fox, Werner Hacke, for the ROCKET AF Steering Committee and Investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1577904303 | ||
| 003 | DE-627 | ||
| 005 | 20220814200802.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180724s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1474-4422(12)70042-X |2 doi | |
| 035 | |a (DE-627)1577904303 | ||
| 035 | |a (DE-576)507904303 | ||
| 035 | |a (DE-599)BSZ507904303 | ||
| 035 | |a (OCoLC)1341014415 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hankey, Graeme |e VerfasserIn |0 (DE-588)1059314126 |0 (DE-627)798283211 |0 (DE-576)41530718X |4 aut | |
| 245 | 1 | 0 | |a Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack |b a subgroup analysis of ROCKET AF |c Graeme J Hankey, Manesh R Patel, Susanna R Stevens, Richard C Becker, Günter Breithardt, Antonio Carolei, Hans-Christoph Diener, Geoffrey A Donnan, Jonathan L Halperin, Kenneth W Mahaffey, Jean-Louis Mas, Ayrton Massaro, Bo Norrving, Christopher C Nessel, John F Paolini, Risto O Roine, Daniel E Singer, Lawrence Wong, Robert M Califf, Keith AA Fox, Werner Hacke, for the ROCKET AF Steering Committee and Investigators |
| 264 | 1 | |c March 7, 2012 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.07.2018 | ||
| 520 | |a Background In ROCKET AF, rivaroxaban was non-inferior to adjusted-dose warfarin in preventing stroke or systemic embolism among patients with atrial fibrillation (AF). We aimed to investigate whether the efficacy and safety of rivaroxaban compared with warfarin is consistent among the subgroups of patients with and without previous stroke or transient ischaemic attack (TIA). | ||
| 700 | 1 | |a Hacke, Werner |d 1948- |e VerfasserIn |0 (DE-588)12021699X |0 (DE-627)080530346 |0 (DE-576)164358854 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet |d London : Lancet Publ. Group, 2002 |g 11(2012), 4, Seite 315-322 |h Online-Ressource |w (DE-627)348587104 |w (DE-600)2079704-7 |w (DE-576)110736362 |x 1474-4465 |7 nnas |a Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack a subgroup analysis of ROCKET AF |
| 773 | 1 | 8 | |g volume:11 |g year:2012 |g number:4 |g pages:315-322 |g extent:8 |a Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack a subgroup analysis of ROCKET AF |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1474-4422(12)70042-X |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://linkinghub.elsevier.com/retrieve/pii/S147444221270042X |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180724 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 12021699X |a Hacke, Werner |m 12021699X:Hacke, Werner |d 910000 |d 911100 |e 910000PH12021699X |e 911100PH12021699X |k 0/910000/ |k 1/910000/911100/ |p 21 |y j | ||
| 999 | |a KXP-PPN1577904303 |e 3019456770 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 24.07.2018"],"recId":"1577904303","language":["eng"],"title":[{"title_sort":"Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack","subtitle":"a subgroup analysis of ROCKET AF","title":"Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack"}],"person":[{"given":"Graeme","family":"Hankey","role":"aut","display":"Hankey, Graeme","roleDisplay":"VerfasserIn"},{"family":"Hacke","given":"Werner","display":"Hacke, Werner","roleDisplay":"VerfasserIn","role":"aut"}],"physDesc":[{"extent":"8 S."}],"relHost":[{"origin":[{"publisherPlace":"London","dateIssuedDisp":"2002-","publisher":"Lancet Publ. Group","dateIssuedKey":"2002"}],"id":{"issn":["1474-4465"],"eki":["348587104"],"zdb":["2079704-7"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"lancet","title":"The lancet"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack a subgroup analysis of ROCKET AFThe lancet","recId":"348587104","language":["eng"],"pubHistory":["1.2002 -"],"part":{"volume":"11","text":"11(2012), 4, Seite 315-322","extent":"8","year":"2012","issue":"4","pages":"315-322"},"titleAlt":[{"title":"The lancet <London> / Neurology"}]}],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"March 7, 2012"}],"id":{"doi":["10.1016/S1474-4422(12)70042-X"],"eki":["1577904303"]},"name":{"displayForm":["Graeme J Hankey, Manesh R Patel, Susanna R Stevens, Richard C Becker, Günter Breithardt, Antonio Carolei, Hans-Christoph Diener, Geoffrey A Donnan, Jonathan L Halperin, Kenneth W Mahaffey, Jean-Louis Mas, Ayrton Massaro, Bo Norrving, Christopher C Nessel, John F Paolini, Risto O Roine, Daniel E Singer, Lawrence Wong, Robert M Califf, Keith AA Fox, Werner Hacke, for the ROCKET AF Steering Committee and Investigators"]}} | ||
| SRT | |a HANKEYGRAERIVAROXABA7201 | ||